Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Grifols, S.A Share Holder Equity 2012-2025 | GRFS

Grifols, S.A share holder equity from 2012 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
  • Grifols, S.A share holder equity for the quarter ending March 31, 2025 was $8.738B, a 2.48% decline year-over-year.
  • Grifols, S.A share holder equity for 2024 was $9.314B, a 7.94% increase from 2023.
  • Grifols, S.A share holder equity for 2023 was $8.629B, a 3.17% decline from 2022.
  • Grifols, S.A share holder equity for 2022 was $8.911B, a 2.93% increase from 2021.
  
Grifols, S.A Annual Share Holder Equity
(Millions of US $)
2024 $9,314
2023 $8,629
2022 $8,911
2021 $8,657
2020 $7,676
2019 $7,667
2018 $5,547
2017 $4,107
2016 $4,125
2015 $3,666
2014 $3,540
2013 $2,799
2012 $2,419
2011 $2,319
Grifols, S.A Quarterly Share Holder Equity
(Millions of US $)
2025-03-31 $8,738
2024-06-30 $8,933
2023-06-30 $8,967
2023-03-31 $8,775
2022-06-30 $8,960
2021-06-30 $8,359
2019-06-30 $5,492
2018-06-30 $4,736
2017-06-30 $3,943
2017-03-31 $4,068
2016-12-31 $4,125
2016-09-30 $3,942
2016-06-30 $3,855
2016-03-31 $3,638
2015-12-31 $3,666
2015-09-30 $3,564
2015-06-30 $3,400
2015-03-31 $3,539
2014-12-31 $3,540
2014-09-30 $3,370
2014-06-30 $3,070
2014-03-31 $3,049
2013-12-31 $2,799
2013-09-30 $2,609
2013-06-30 $2,540
2013-03-31 $2,587
2012-12-31 $2,419
2012-09-30 $2,320
2012-06-30 $2,362
2012-03-31 $2,209
2011-12-31 $2,319
2011-09-30 $2,263
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $7.219B $7.805B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $81.255B 31.25
Zoetis (ZTS) United States $67.231B 25.08
Daiichi Sankyo, - (DSNKY) Japan $46.317B 23.74
Takeda Pharmaceutical (TAK) Japan $45.565B 9.06
BeOne Medicines - (ONC) Cayman Islands $33.509B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.995B 0.00
Summit Therapeutics (SMMT) United States $19.859B 0.00
Merck (MKKGY) Germany $16.905B 12.39
Shionogi (SGIOY) Japan $14.275B 14.30
United Therapeutics (UTHR) United States $13.422B 11.87
Neurocrine Biosciences (NBIX) United States $13.280B 45.49
Orion OYJ (ORINY) Finland $11.409B 27.50
IPSEN (IPSEY) France $10.846B 0.00
Stevanato Group S.p.A (STVN) Italy $7.653B 46.80
Corcept Therapeutics (CORT) United States $7.232B 58.79
Ionis Pharmaceuticals (IONS) United States $6.602B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.537B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.204B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.232B 0.00
Hypermarcas (HYPMY) Brazil $2.971B 19.54
Crinetics Pharmaceuticals (CRNX) United States $2.741B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.563B 8.98
NewAmsterdam Pharma (NAMS) Netherlands $2.558B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.536B 13.71
Centessa Pharmaceuticals (CNTA) United Kingdom $2.032B 0.00
Ocular Therapeutix (OCUL) United States $1.872B 0.00
Endo (NDOI) United States $1.813B 0.00
ARS Pharmaceuticals (SPRY) United States $1.743B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.693B 0.00
Evotec AG (EVO) Germany $1.506B 0.00
Dyne Therapeutics (DYN) United States $1.309B 0.00
Guardian Pharmacy Services (GRDN) United States $1.287B 0.00
Harrow (HROW) United States $1.267B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.209B 24.18
Avadel Pharmaceuticals (AVDL) Ireland $1.028B 0.00
Ardelyx (ARDX) United States $1.010B 0.00
Collegium Pharmaceutical (COLL) United States $1.003B 5.41
Enliven Therapeutics (ELVN) United States $0.985B 0.00
Akebia Therapeutics (AKBA) United States $0.922B 0.00
ProKidney (PROK) United States $0.811B 0.00
Xeris Biopharma Holdings (XERS) United States $0.782B 0.00
Cronos Group (CRON) Canada $0.775B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.709B 0.00
KalVista Pharmaceuticals (KALV) United States $0.687B 0.00
Xencor (XNCR) United States $0.628B 0.00
Relay Therapeutics (RLAY) United States $0.621B 0.00
Organogenesis (ORGO) United States $0.605B 0.00
Zevra Therapeutics (ZVRA) United States $0.591B 0.00
Elite Pharmaceuticals (ELTP) United States $0.585B 0.00
Tourmaline Bio (TRML) United States $0.583B 0.00
USANA Health Sciences (USNA) United States $0.564B 11.33
Theravance Biopharma (TBPH) United States $0.552B 0.00
Bioventus (BVS) United States $0.537B 13.62
Oruka Therapeutics (ORKA) United States $0.514B 0.00
Siga Technologies (SIGA) United States $0.501B 10.46
Savara (SVRA) United States $0.453B 0.00
Aquestive Therapeutics (AQST) United States $0.390B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.356B 9.61
AleAnna (ANNA) United States $0.354B 0.00
Nanobiotix S.A (NBTX) France $0.327B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.314B 0.00
Altimmune (ALT) United States $0.311B 0.00
Aldeyra Therapeutics (ALDX) United States $0.305B 0.00
Esperion Therapeutics (ESPR) United States $0.291B 0.00
Nektar Therapeutics (NKTR) United States $0.284B 0.00
Heron Therapeutics (HRTX) United States $0.282B 0.00
Nature's Sunshine Products (NATR) United States $0.270B 24.83
OmniAb (OABI) United States $0.239B 0.00
Larimar Therapeutics (LRMR) United States $0.226B 0.00
MediWound (MDWD) Israel $0.214B 0.00
Galectin Therapeutics (GALT) United States $0.209B 0.00
4D Molecular Therapeutics (FDMT) United States $0.202B 0.00
Lyell Immunopharma (LYEL) United States $0.191B 0.00
China SXT Pharmaceuticals (SXTC) China $0.179B 0.00
Journey Medical (DERM) United States $0.177B 0.00
Liminatus Pharma (LIMN) United States $0.174B 0.00
Aclaris Therapeutics (ACRS) United States $0.168B 0.00
Profound Medical (PROF) Canada $0.164B 0.00
Avita Medical (RCEL) United States $0.152B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.144B 0.00
Korro Bio (KRRO) United States $0.142B 0.00
Lexeo Therapeutics (LXEO) United States $0.136B 0.00
Protara Therapeutics (TARA) United States $0.128B 0.00
Inhibikase Therapeutics (IKT) United States $0.126B 0.00
Cardiol Therapeutics (CRDL) Canada $0.121B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cassava Sciences (SAVA) United States $0.107B 0.00
VAXART, INC (VXRT) United States $0.091B 0.00
Fractyl Health (GUTS) United States $0.089B 0.00
Vivani Medical (VANI) United States $0.089B 0.00
Achieve Life Sciences (ACHV) Canada $0.088B 0.00
Champions Oncology (CSBR) United States $0.088B 20.06
Metagenomi (MGX) United States $0.088B 0.00
Nutriband (NTRB) United States $0.084B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Surrozen (SRZN) United States $0.079B 0.00
PMV Pharmaceuticals (PMVP) United States $0.075B 0.00
Context Therapeutics (CNTX) United States $0.074B 0.00
Dominari Holdings (DOMH) United States $0.071B 0.00
Avalo Therapeutics (AVTX) United States $0.071B 0.00
Pyxis Oncology (PYXS) United States $0.071B 0.00
Rafael Holdings (RFL) United States $0.070B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Assertio Holdings (ASRT) United States $0.068B 0.00
Wellgistics Health (WGRX) United States $0.067B 0.00
Telomir Pharmaceuticals (TELO) United States $0.061B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
DURECT (DRRX) United States $0.058B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.058B 0.00
Unicycive Therapeutics (UNCY) United States $0.056B 0.00
BioNxt Solutions (BNXTF) Canada $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 38.78
ElectroCore (ECOR) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
NRx Pharmaceuticals (NRXP) United States $0.050B 0.00
Gain Therapeutics (GANX) United States $0.047B 0.00
Prelude Therapeutics (PRLD) United States $0.047B 0.00
Jupiter Neurosciences (JUNS) United States $0.047B 0.00
Klotho Neurosciences (KLTO) United States $0.044B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
Mural Oncology (MURA) Ireland $0.041B 0.00
Karyopharm Therapeutics (KPTI) United States $0.036B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Enlivex Therapeutics (ENLV) Israel $0.034B 0.00
Plus Therapeutics (PSTV) United States $0.032B 0.00
Incannex Healthcare (IXHL) Australia $0.031B 0.00
Iterum Therapeutics (ITRM) Ireland $0.030B 0.00
FibroGen (FGEN) United States $0.029B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.027B 0.00
Vivos Therapeutics (VVOS) United States $0.026B 0.00
Scienture Holdings (SCNX) United States $0.026B 0.00
Cosmos Health (COSM) United States $0.024B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.023B 0.00
VYNE Therapeutics (VYNE) United States $0.022B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
CASI Pharmaceuticals (CASI) China $0.019B 0.00
Mannatech (MTEX) United States $0.018B 0.00
BioLineRx (BLRX) Israel $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Carisma Therapeutics (CARM) United States $0.014B 0.00
Minerva Neurosciences (NERV) United States $0.014B 2.38
TherapeuticsMD (TXMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
BioVie (BIVI) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.010B 0.00
TransCode Therapeutics (RNAZ) United States $0.010B 0.00
Lyra Therapeutics (LYRA) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Aptorum Group (APM) United Kingdom $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 10.10
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00